DCF — ENCOMPASS HEALTH DEACONESS REHABILIT
Enterprise Value: $32.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$32.0M
Enterprise Value
$8.1M
PV of Cash Flows
$23.8M
PV of Terminal Value
$38.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $51.7M | $4.4M | 9.0% | $1.4M | $1.3M |
| Year 2 | $53.2M | $5.1M | 10.0% | $1.9M | $1.5M |
| Year 3 | $54.8M | $5.8M | 11.0% | $2.3M | $1.8M |
| Year 4 | $56.5M | $6.2M | 11.0% | $2.6M | $1.8M |
| Year 5 | $58.2M | $6.5M | 11.0% | $2.8M | $1.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $32.0M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$50.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000557850502
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5